|Funding for:||UK Students, EU Students, International Students|
|Funding amount:||Stipend for 2023-24 is £18,622|
|Placed On:||28th September 2023|
|Closes:||13th October 2023|
A 3.5 -year fully-funded PhD studentship, including international fee, is offered to explore the use of cutting-edge technologies and novel vaccine platforms for the development of vaccines against E. coli. Infections caused by E. coli in humans and animals result in significant morbidity and mortality. The emergence of antimicrobial resistance is making infections more difficult to treat. The high variability of isolates, virulence factors and pathogenic presentations of infections by E. coli poses a significant challenge for the development of cost-effective vaccines. In this project, the student will leverage recent technologies and synergies between the veterinary and human vaccinology fields to identify relevant antigen targets, create tools to support vaccine development and ultimately create and evaluate novel vaccine candidates against E. coli infections.
Open to any UK or international candidates. Starting in January 2024.
You will need to meet the minimum entry requirements for our PhD programme.
Experience in vaccinology, vaccine immunology and bacteriology is desirable.
How to apply
Applications should be submitted via the Biosciences and Medicine PhD programme page, mentioning this project AND emailed to Prof Rollier at firstname.lastname@example.org by the deadline. In your application, please mention this studentship. Instead of a project proposal, upload a covering letter, indicating why you have applied and what you hope to achieve by undertaking this PhD. Your CV should include your course modules and marks (including predicted grade if you are in your final year).
Covers fees and stipend (the stipend for 2023-24 is £18,622) for 3.5 years and £18,000 (£6,000/year for 3 years) towards project costs. This studentship is partially supported by philanthropic funding.
Friday 13 October 2023
Contact Prof Christine Rollier (email@example.com).
Type / Role: